Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors

• 30 June 2005
• journal article
• review article
• Published by Elsevier in Current Opinion in Pharmacology
• Vol. 5  (3) , 238-244
• https://doi.org/10.1016/j.coph.2005.04.001

Abstract

Keywords

• LUNG
• EFFICACY
• ASTHMA
• PHOSPHODIESTERASE
• PDE5
• PDE4
• III
• DUAL SPECIFICITY
• HAMPER